arrow
Back
C

Christoffer Gebhardt

University Medical Center Hamburg-Eppendorf

36H-index
267Paper Count
9.4KCitation Count
Published Papers 114
Publication Date
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma
err2026-08-15
err0
errOAAI
errJulian Kött; Glenn Geidel; Carmen M. T. Roeper; Lucija Ačkar; Bente Siebels; Hannah Voß; Hartmut Schlüter; Michaela Schweizer; Kilian Müller; Alessandra Rünger; Tim Zell; Benjamin Deitert; Ali Zeinal-Abedini; Isabel Heidrich; Stefan W. Schneider; Klaus Pantel; Daniel J. Smit; Christoffer Gebhardt
errShare
errSave
Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study
err2026-07-25
err0
errOAAI
errMK Miso Kim; EM Elizabeth M. Gaughan; AA Agueda Azpeitia; AR Aparna Rao; ML Maria L. Wei; AS Alexandra So; XZ Xiaochen Zhong; CB Carola Berking; RJ Ruixuan Jiang; SD Stéphane Dalle; CR Caroline Robert; SA Salma Alam; TD Tessa Davies; DD Dirk Debus; MD Marcin Dzienis; SD Sarah Danson; RF Ricky Frazer; CG Christoffer Gebhardt; GG Glenn Geidel; JC Jessica C. Hassel; IH Inga Hansen; MV Markus V. Heppt; LH Lina Hildebrandt; JI James Isaacs; KJ Koung Jin Suh; BK Bhumsuk Keam; YJ Yu Jung Kim; TL Thierry Lesimple; PS Phillipe Saiag; RW Ryan Weight; AD Alicia Delibes; RB Rosemarie Barnett; CK Clemens Krepler; KG Kavita Gandhi; NQ Nawab Qizilbash; IS Irene Shui; XT Xiang-Lin Tan; RJ Ryan J. Sullivan
errShare
errSave
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma
err2026-07-21
err0
PREAI
errAlexander CJ van Akkooi; Michal Kicinski; Anne-Sophie Govaerts; Axel Hauschild; Piotr Rutkowski; Petr Arenberger; Paolo A. Ascierto; Piotr Tomczak; Gaëlle Quereux; Federica De Galitiis; Caroline Dutriaux; Christoffer Gebhardt; Ellen Kapiteijn; Laurent Machet; Miguel GA Berciano; Michele Del Vecchio; Mathilde Jalving; Thomas Jouary; Ivana Krajsova; Suzana Matkovic
errShare
errSave
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy
err2026-07-03
err0
errOAAI
errIsabel Heidrich; Sarah Urhahn; Christoffer Gebhardt; Daniel J. Smit; Klaus Pantel
errShare
errSave
Perioperative PD-1-inhibition in melanoma patients – a retrospective analysis from eight German skin cancer centers
err2026-07-01
err0
PREAI
errNina Flatt; Corinna Kochanek; Yenny Angela; Jessica C Hassel; Andrea Forschner; Christoffer Gebhardt; Miriam Mengoni; Kai-Martin Thoms; Markus Heppt; Julian Kött; Carsten Schulz; Lukas Flatz; Thomas Tüting; Mareike Alter; Katrin Schaper-Gerhardt; Ralf Gutzmer
errShare
errSave
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026
err2026-05-07
err0
errOAAI
errAlexander J. Stratigos; Clio Dessinioti; Claus Garbe; Celeste Lebbe; Teresa Amaral; Veronique Bataille; Brigitte Dreno; Reinhard Dummer; Maria Concetta Fargnoli; Ana Maria Forsea; Christoffer Gebhardt; Catherine A. Harwood; Axel Hauschild; Christoph Hoeller; Lidija Kandolf-Sekulovic; Roland Kaufmann; Nicole WJ Kelleners-Smeets; Peter Koelblinger; Aimilios Lallas; Ulrike Leiter
errShare
errSave
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition
err2026-04-27
err0
errOAAI
errTim Zell; Julian Kött; Noah Zimmermann; Greta Ancker; Alexander T. Bauer; Daniel J. Smit; Glenn Geidel; Julian C. Gerwers; Thomas Renné; Sebastian A. Wohlfeil; Jochen Utikal; Stefan W. Schneider; Christoffer Gebhardt
errShare
errSave
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study
err2026-03-15
err0
errOAAI
errRalf Gutzmer; Michael Weichenthal; Thomas Eigentler; Peter Mohr; Thomas Sickmann; Pia Dücker; Christoffer Gebhardt; Sebastian Haferkamp; Katharina C. Kähler; Friedegund Meier; Claudia Pföhler; Anca Sindrilaru; Patrick Terheyden; Imke von Wasielewski; Selma Ugurel; Jens Ulrich; Jochen Utikal; Carsten Weishaupt; Dirk Schadendorf
errShare
errSave
Successful Multimodal Therapeutic Approach for CD30-positive Folliculotropic Mycosis Fungoides
err2026-03-06
err0
errOAAI
errChiara L. Blomen; Inga Hansen-Abeck; Andrea Baehr; Stefan W. Schneider; Christoffer Gebhardt; Nina Booken
errShare
errSave
Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated Melanoma
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errJulian Kött; Myriam Merkle; Lina Bergmann; Noah Zimmermann; Tim Zell; Isabel Heidrich; Glenn Geidel; Klaus Pantel; Stefan W. Schneider; Christoffer Gebhardt; Daniel J. Smit
errShare
errSave
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
err2026-02-20
err0
errOAAI
errKonstantinos Lallas; Lena Nanz; Selma Ugurel; Peter Mohr; Friedegund Meier; Michael Weichenthal; Imke von Wasielewski; Patrick Terheyden; Jessica Hassel; Alexander Kreuter; Rudolf Herbst; Anja Gesierich; Claudia Pföhler; Ralf Gutzmer; Julia Welzel; Christoffer Gebhardt; Sebastian Haferkamp; Jens Ulrich; Martin Kaatz; Frank Meiss
errShare
errSave
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
err2026-01-29
err0
errOAAI
errGlenn Geidel; Sabrina Bänsch; Laura Adam; Nathan Fekade; Alessandra Rünger; Tim Zell; Daniel J. Smit; Julian Kött; Isabel Heidrich; Michael Weichenthal; Selma Ugurel; Ulrike Leiter; Peter Mohr; Alexandra Geusau; Stephan Grabbe; Markus V. Heppt; Ralf Gutzmer; Jochen Utikal; Jan-Christoph Simon; Sebastian Haferkamp; Laura Susok; Bastian Schilling; Edgar Dippel; Imke von Wasielewski; Jessica C. Hassel; Carola Berking; Stefan W. Schneider; Christoffer Gebhardt
errShare
errSave
Circulating cellular communication network factor 1 (CCN1) as a liquid biopsy marker indicating progression in advanced melanoma
err2026-01-21
err0
errOAAI
errIsabel Heidrich; Kim-Lea Reese; Helen Ullemeyer; Julian Kött; Hanna Freiberg; Glenn Geidel; Alessandra Rünger; Inga Hansen-Abeck; Finn Abeck; Stefan W. Schneider; Christoffer Gebhardt; Klaus Pantel; Daniel J. Smit
errShare
errSave
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors
err2026-01-16
err0
errOAAI
errViola K DeTemple; Rudolf Stadler; Sabine Bredemeier; Sungyoung Chung; Katrin Schaper-Gerhardt; Mareike Alter; Yenny Angela; Henner Stege; Ulrike Leiter; Jan Ohletz; Elisabeth Livingstone; Imke von Wasielewski; Jessica C Hassel; Julia Huynh; Christoffer Gebhardt; Claudia Pföhler; Ralf Gutzmer; Christina H Scheel
errShare
errSave
Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project
err2025-12-31
err0
errOAAI
errGebhardt, Christoffer; Debus, Dirk; Rohrer, Peter; Kahler, Katharina C.; Koch, Lukas; Terheyden, Patrick; Nguyen, Van Anh
errShare
errSave
Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients
err2025-08-30
err0
PREAI
errSelma Ugurel; Nessr Abu Rached; Thilo Gambichler; Miriam Mengoni; Thomas Tüting; Jessica C. Hassel; Robin Reschke; Georg C. Lodde; Jan-Malte Placke; Dirk Schadendorf; Lydia Reinhardt; Alexander Kreuter; Martin Gschnell; Jochen Utikal; Michael Erdmann; Pia Dücker; Doris Helbig; Cindy Franklin; Christoffer Gebhardt; Gabriela Poch; Katharina C. Kähler; Michael Weichenthal; Ralf Gutzmer; Lucie Heinzerling; Carsten Weishaupt; Peter Mohr; Kai-Martin Thoms; Berenice Lang; Bastian Schilling; Sebastian Haferkamp; Michael Sachse; Julia Welzel; Franziska Jochims; Ulrike Raap; Gaston Schley; Patrick Terheyden; Edgar Dippel; Christoph Pöttgen; Jürgen C. Becker; Alpaslan Tasdogan; Teresa Amaral; Lena Nanz; Ulrike Leiter
errShare
errSave
Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
err2025-07-29
err0
errOAAI
errAnna-Sophia Leven; Triinu Peters; Luisa Sophie Rajcsanyi; Michael Weichenthal; Peter Mohr; Friedegund Meier; Imke von Wasielewski; Ralf Gutzmer; Jochen Utikal; Patrick Terheyden; Rudolf Herbst; Sebastian Haferkamp; Claudia Pföhler; Ulrike Leiter; Andrea Forschner; Alexander Kreuter; Christoffer Gebhardt; Stine Lutze; Carsten Weishaupt; Stephan Grabbe; Dirk Debus; Jessica Hassel; Julia Welzel; Lucie Heinzerling; Carola Berking; Carmen Loquai; Thilo Gambichler; Mirjana Ziemer; Jürgen C. Becker; Alpaslan Tasdogan; Lisa Zimmer; Elisabeth Livingstone; Dirk Schadendorf; Alexander Roesch; Anke Hinney; Selma Ugurel
errShare
errSave
Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma
err2025-07-10
err0
errOAAI
errGlenn Geidel; Laura Adam; Sabrina Bänsch; Nathan Fekade; Sarah Degenhardt; Alessandra Rünger; Julian Kött; Tim Zell; Isabel Heidrich; Daniel J. Smit; Rüdiger Greinert; Beate Volkmer; Klaus Pantel; Peter Mohr; Axel Hauschild; Stefan W. Schneider; Christoffer Gebhardt
errShare
errSave